Analysts expect Xenetic Biosciences, Inc. to report revenue of 1.38 M for Q3 26, against a range of 1.32 M to 1.44 M. The most recent reported quarter, Q2 26, came in at 660,600.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 614,240.00 | 650,000.00 | 590,000.00 | 589,897.00 | 1.03 M | 766,296.00 | 806,920.00 | 660,600.00 | - | - | - | - | - | - | - | - | ||||||
| High Estimate | 827,179.06 | 724,607.29 | 755,382.66 | 665,441.97 | 685,787.82 | 752,323.06 | - | - | 1.44 M | 1.00 M | 597,246.21 | 470,737.53 | 1.00 M | 630,172.84 | 1.98 M | 1.79 M | ||||||
| Low Estimate | 773,185.94 | 651,442.71 | 653,600.54 | 606,426.03 | 623,679.78 | 691,833.14 | - | - | 1.32 M | 890,649.95 | 494,987.97 | 440,430.27 | 830,180.07 | 548,239.04 | 1.75 M | 1.51 M | ||||||
| Consensus Estimate | 800,182.50 | 688,025.00 | 704,491.60 | 635,934.00 | 654,733.80 | 722,078.10 | - | - | 1.38 M | 946,980.11 | 546,117.09 | 455,583.90 | 916,760.79 | 589,205.94 | 1.86 M | 1.65 M |
Analysts expect Xenetic Biosciences, Inc. to report earnings per share of -0.36 for Q3 26, against a range of -0.38 to -0.34. The most recent reported quarter, Q2 26, came in at -0.41.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.28 | -0.68 | -0.59 | -0.45 | -0.33 | -0.34 | -0.20 | -0.41 | - | - | - | - | - | - | - | - | ||||||
| High Estimate | -0.12 | -0.62 | -0.74 | -0.60 | -0.43 | -0.44 | - | - | -0.34 | -0.63 | -0.08 | -0.07 | 0.07 | -0.23 | -0.03 | -0.08 | ||||||
| Low Estimate | -0.14 | -0.70 | -0.80 | -0.72 | -0.51 | -0.54 | - | - | -0.38 | -0.67 | -0.10 | -0.07 | 0.07 | -0.27 | -0.03 | -0.08 | ||||||
| Consensus Estimate | -0.13 | -0.66 | -0.77 | -0.66 | -0.47 | -0.49 | - | - | -0.36 | -0.65 | -0.09 | -0.07 | 0.07 | -0.25 | -0.03 | -0.08 |
Pull Wall Street consensus for Xenetic Biosciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=XBIO&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "XBIO", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=XBIO&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();